Archive for May 2022

Clincal Trials and Tribulations Newsletter – May 2022 Edition

Clinical Trials and Tribulations Newsletter - May 2022

Welcome to the May edition of AARDEX Group’s Clinical Trials and Tribulations Newsletter – an aggregated collective of all of the industry’s hottest news and views!  Breaking News New Pivotal Data Demonstrates the Clinical Benefit of Roche’s glofitamab, a Potential First-in-Class Bispecific Antibody for People with Aggressive Lymphoma Roche today announced that new pivotal data…

Read More

In a world of outcome-based pricing, can you afford to neglect patient adherence? 

Poor Patient Adherence

The emergence of outcome-based contracts in clinical research has placed an additional consideration on the already thorny issue of adherence. When drug companies are paid according to the real-world effectiveness of their products, ensuring people take the medications as prescribed is essential to the all-important return on investment (ROI). Modern approaches, such as digital adherence…

Read More

Harnessing Smart Pill Bottles to Improve Patient Adherence in Clinical Research

smart pill bottles

“Nothing stops a drug from working like not taking it, making patient adherence one of the most important factors to consider when designing a clinical trial.”  – Bernard Vrijens, Scientific Lead, AARDEX® Group Poor patient adherence is a problem that has gone “unsolved” for decades. But combining smart pill bottle technology with individualized feedback can drive…

Read More